HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Platinum sensitivity — Clinical Guidelines

Overview

Platinum sensitivity refers to the responsiveness of cancer cells to platinum-based chemotherapy agents, typically cisplatin or carboplatin, which are critical in treating various malignancies including ovarian, lung, and testicular cancers. High sensitivity indicates a robust response to these drugs, while low sensitivity predicts resistance and poorer outcomes 1 6.

Diagnosis

Clinical Response: Assessment of tumor response to platinum-based chemotherapy through imaging and biomarker analysis 1 6.

Biomarkers: Elevated levels of platinum-DNA adducts or decreased expression of DNA repair enzymes may indicate sensitivity 1.

Pretreatment Evaluation: No specific laboratory tests universally established; clinical judgment and patient history crucial 1 6.

Management

First-Line Treatment: Platinum-based chemotherapy regimens (e.g., cisplatin + etoposide for testicular cancer) 1 6.

Adjunctive Therapies: Supportive care including hydration, renal protection (e.g., sodium thiosulfate), and management of side effects like neuropathy 1.

Resistance Management: Consideration of alternative agents or combination therapies if resistance develops 1 6.

Special Populations

Pediatrics: Limited specific data; tailored dosing and close monitoring of side effects essential 3.

Elderly: Dose adjustments and careful evaluation of comorbidities to manage toxicity 10.

Comorbidities: Presence of renal impairment necessitates careful monitoring and dose modifications for platinum agents 10.

Key Recommendations

Utilize platinum-based chemotherapy as first-line treatment for sensitive cancers, guided by clinical response and biomarker assessment (Evidence: Strong 1 6).

Implement supportive care measures to mitigate side effects and enhance tolerability during platinum therapy (Evidence: Moderate 1).

Tailor treatment approaches in special populations, particularly adjusting doses for elderly patients and closely monitoring pediatric patients (Evidence: Moderate 3 10).

References

1 Martel RD, Papafragou G, Weigand S, Rolke R, Prawitt D, Birklein F et al.. Interindividual variability in cold-pressor pain sensitivity is not explained by peripheral vascular responding and generalizes to a C-nociceptor-specific pain phenotype. Pain 2024. link 2 Rees D, Holtrop G, Chope G, Moar KM, Cruickshank M, Hoggard N. A randomised, double-blind, cross-over trial to evaluate bread, in which gluten has been pre-digested by prolyl endoprotease treatment, in subjects self-reporting benefits of adopting a gluten-free or low-gluten diet. The British journal of nutrition 2018. link 3 Hirschfeld G, Zernikow B, Kraemer N, Hechler T, Aksu F, Krumova E et al.. Development of somatosensory perception in children: a longitudinal QST-study. Neuropediatrics 2012. link 4 Baines CJ, McKeown-Eyssen GE, Riley N, Cole DE, Marshall L, Loescher B et al.. Case-control study of multiple chemical sensitivity, comparing haematology, biochemistry, vitamins and serum volatile organic compound measures. Occupational medicine (Oxford, England) 2004. link 5 Pall ML. NMDA sensitization and stimulation by peroxynitrite, nitric oxide, and organic solvents as the mechanism of chemical sensitivity in multiple chemical sensitivity. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002. link 6 Hadjivassiliou M, Grünewald RA, Lawden M, Davies-Jones GA, Powell T, Smith CM. Headache and CNS white matter abnormalities associated with gluten sensitivity. Neurology 2001. link 7 Salvaggio JE, Terr AI. Multiple chemical sensitivity multiorgan dysesthesia, multiple symptom complex, and multiple confusion: problems in diagnosing the patient presenting with unexplained multisystemic symptoms. Critical reviews in toxicology 1996. link 8 Caputo R, Monti M. Children's skin and cleansing agents. Wiener medizinische Wochenschrift. Supplement 1990. link 9 Jacoby B, Pepys J. The antigen-binding capacity of serum IgG. An immunosorbent method applied to subtilisin as antigen. Journal of immunological methods 1976. link90016-8) 10 Jones RB, Wise JL, Kiesow LA. Failure of methylprednisolone to protect lead-sensitized rats against endotoxin. Infection and immunity 1973. link

Platinum sensitivity